In response to general questions about its business practices, Mochi Health said in a statement that it offers compounded GLP-1 medications that are customized for medical necessity." Their use remains appropriate and legal when tailored to individual patient needs and prescribed by a licensed medical providernot as mass-market substitutes for branded medications, Mochi Health said
Keep in mind how and why L cells produce GLP-1s The L cell mechanism related to GLP-1 release underscores the different factors related to metabolic homeostasis
Together, these actions: Increase insulin release only when blood glucose is elevated Reduce excess glucose production by the liver Slow stomach emptying, limiting post-meal glucose spikes Act on appetite centres in the brain, increasing fullness and reducing hunger Because insulin release is glucose-dependent, Mounjaro on its own has a low risk of causing hypoglycaemia (low blood sugar), unless combined with insulin or sulfonylurea medications
doi: 10.1083/jcb.200210169
A great product for enhancing both scalp and hair health
Neurodegenerative therapies have historically been met with challenges during development, so its exciting to see potential in this area for GLP-1 analogues